|
1
|
Friend PA: Pulmonary infection in cystic
fibrosis. J Infect. 13:55–72. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kulczycki LL, Murphy TM and Bellanti JA:
Pseudomonas colonization in cystic fibrosis. A study of 160
patients. JAMA. 240:30–34. 1978. View Article : Google Scholar
|
|
3
|
May JR, Herrick NC and Thompson D:
Bacterial infection in cystic fibrosis. Arch Dis Child. 47:908–913.
1972. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mearns MB, Hunt GH and Rushworth R:
Bacterial flora of respiratory tract in patients with cystic
fibrosis, 1950–1971. Arch Dis Child. 47:902–907. 1972.PubMed/NCBI
|
|
5
|
Thomassen MJ, Demko CA, Boxerbaum B, et
al: Multiple isolates of Pseudomonas aeruginosa with
differing antimicrobial susceptibility patterns from patients with
cystic fibrosis. J Infect Dis. 140:873–880. 1979.
|
|
6
|
Arancibia F, Bauer TT, Ewig S, et al:
Community-acquired pneumonia due to gram-negative bacteria and
Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch
Intern Med. 162:1849–1858. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
West SE, Zeng L, Lee BL, et al:
Respiratory infections with Pseudomonas aeruginosa in
children with cystic fibrosis: early detection by serology and
assessment of risk factors. JAMA. 287:2958–2967. 2002.PubMed/NCBI
|
|
8
|
Spilker T, Coenye T, Vandamme P and LiPuma
JJ: PCR-based assay for differentiation of Pseudomonas
aeruginosa from other Pseudomonas species recovered from
cystic fibrosis patients. J Clin Microbiol. 42:2074–2079.
2004.PubMed/NCBI
|
|
9
|
Gillespie SH and Hawkey PM: Principles and
Practice of Clinical Bacteriology. 2nd edition. Wiley; Chichester,
UK: 2006, View Article : Google Scholar
|
|
10
|
Lyczak JB, Cannon CL and Pier GB: Lung
infections associated with cystic fibrosis. Clin Microbiol Rev.
15:194–222. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nikaido H: Multidrug efflux pumps of
gram-negative bacteria. J Bacteriol. 178:5853–5859. 1996.PubMed/NCBI
|
|
12
|
Sonnesyn SW and Gerding DN: Antimicrobials
for the treatment of respiratory infections. Respiratory
Infections: A Scientific Basis for Management. Niederman MS, Sarosi
GA and Glassroth J: Saunders; Philadelphia: pp. 511–537. 1994
|
|
13
|
Lee K, Lim YS, Yong D, et al: Evaluation
of the Hodge test and the imipenem-EDTA double-disk synergy test
for differentiating metallo-beta-lactamase-producing isolates of
Pseudomonas spp. and Acinetobacter spp. J Clin
Microbiol. 41:4623–4629. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Varaiya A, Kulkarni N, Kulkarni M, et al:
Incidence of metallo beta lactamase producing Pseudomonas
aeruginosa in ICU patients. Indian J Med Res. 127:398–402.
2008.PubMed/NCBI
|
|
15
|
Oh EJ, Lee S, Park YJ, et al: Prevalence
of metallo-beta-lactamase among Pseudomonas aeruginosa and
Acinetobacter baumannii in a Korean university hospital and
comparison of screening methods for detecting
metallo-beta-lactamase. J Microbiol Methods. 54:411–418.
2003.PubMed/NCBI
|
|
16
|
Pitout JD, Gregson DB, Poirel L, et al:
Detection of Pseudomonas aeruginosa producing
metallo-beta-lactamases in a large centralized laboratory. J Clin
Microbiol. 43:3129–3135. 2005.
|
|
17
|
Gladstone P, Rajendran P and Brahmadathan
KN: Incidence of carbapenem resistant nonfermenting gram negative
bacilli from patients with respiratory infections in the intensive
care units. Indian J Med Microbiol. 23:189–191. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cornaglia G, Mazzariol A, Lauretti L, et
al: Hospital outbreak of carbapenem-resistant Pseudomonas
aeruginosa producing VIM-1, a novel transferable
metallo-beta-lactamase. Clin Infect Dis. 31:1119–1125.
2000.PubMed/NCBI
|
|
19
|
Crespo MP, Woodford N, Sinclair A, et al:
Outbreak of carbapenem-resistant Pseudomonas aeruginosa
producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care
center in Cali, Colombia. J Clin Microbiol. 42:5094–5101.
2004.PubMed/NCBI
|
|
20
|
Pournaras S, Maniati M, Petinaki E, et al:
Hospital outbreak of multiple clones of Pseudomonas
aeruginosa carrying the unrelated metallo-beta-lactamase gene
variants blaVIM-2 and blaVIM-4.
J Antimicrob Chemother. 51:1409–1414. 2003.
|
|
21
|
Tsakris AS, Pournaras S, Woodford M, et
al: Outbreak of infections caused by Pseudomonas aeruginosa
producing VIM-1 carbapenemase in Greece. J Clin Microbiol.
38:1290–1292. 2000.
|
|
22
|
Yong D, Lee K, Yum JH, et al:
Imipenem-EDTA disk method for differentiation of
metallo-beta-lactamase-producing clinical isolates of
Pseudomonas spp. and Acinetobacter spp. J Clin
Microbiol. 40:3798–3801. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Clinical and Laboratory Standards
Institute (CLSI). Performance standards for antimicrobial
susceptibility testing. 11th informational supplement. CLSI; Wayne,
PA, USA: pp. M100–S23. 2013
|
|
24
|
Hall BG and Barlow M: Revised Ambler
classification of β-lactamases. J Antimicrob Chemother.
55:1050–1051. 2005.PubMed/NCBI
|
|
25
|
Pitt TL, Sparrow M, Warner M and
Stefanidou M: Survey of resistance of Pseudomonas aeruginosa
from UK patients with cystic fibrosis to six commonly prescribed
antimicrobial agents. Thorax. 58:794–796. 2003.PubMed/NCBI
|
|
26
|
Cheng K, Smyth RL, Govan JR, et al: Spread
of beta-lactam-resistant Pseudomonas aeruginosa in a cystic
fibrosis clinic. Lancet. 348:639–642. 1996.PubMed/NCBI
|
|
27
|
Gales AC, Jones RN, Turnidge J, et al:
Characterization of Pseudomonas aeruginosa isolates:
occurrence rates, antimicrobial susceptibility patterns, and
molecular typing in the global SENTRY antimicrobial surveillance
program, 1997–1999. Clin Infect Dis. 32(Suppl 2): S146–S155.
2001.
|
|
28
|
Neuhauser MM, Weinstein RA, Rydman R, et
al: Antibiotic resistance among gram-negative bacilli in US
intensive care units: implications for fluoroquinolone use. JAMA.
289:885–888. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cardoso O, Alves AF and Leitão R:
Metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa
isolates from a cystic fibrosis patient. Int J Antimicrob Agents.
31:375–379. 2008.PubMed/NCBI
|
|
30
|
Manoharan A, Chatterjee S and Mathai D;
SARI Study Group. Detection and characterization of metallo beta
lactamases producing Pseudomonas aeruginosa. Indian J Med
Microbiol. 28:241–244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Behera B, Mathur P, Das A, et al: An
evaluation of four different phenotypic techniques for detection of
metallo-beta-lactamase producing Pseudomonas aeruginosa.
Indian J Med Microbiol. 26:233–237. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hemlatha V, Sekar U and Kamat V: Detection
of metallo betalactamase producing Pseudomonas aeruginosa in
hospitalized patients. Indian J Med Res. 122:148–152.
2005.PubMed/NCBI
|
|
33
|
Hemlatha V, Sekar U and Kamat V: Detection
of metallo betalactamase producing Pseudomonas aeruginosa in
hospitalized patients. Indian J Med Res. 122:148–152.
2005.PubMed/NCBI
|
|
34
|
Mayank D, Anshuman M, Singh RK, et al:
Nosocomial cross-transmission of Pseudomonas aeruginosa
between patients in a tertiary intensive care unit. Indian J Pathol
Microbiol. 52:509–513. 2009.
|
|
35
|
Obritsch MD, Fish DN, MacLaren R and Jung
R: National surveillance of antimicrobial resistance in
Pseudomonas aeruginosa isolates obtained from intensive care
unit patients from 1993 to 2002. Antimicrob Agents Chemother.
48:4606–4610. 2004.PubMed/NCBI
|
|
36
|
Arya M, Arya PK, Biswas D and Prasad R:
Antimicrobial susceptibility pattern of bacterial isolates from
post-operative wound infections. Indian J Pathol Microbiol.
48:266–269. 2005.PubMed/NCBI
|
|
37
|
Migliavacca R, Docquier JD, Mugnaioli C,
et al: Simple microdilution test for detection of
metallo-β-lactamase production in Pseudomonas aeruginosa. J
Clin Microbiol. 40:4388–4390. 2002.
|
|
38
|
Aggarwal R, Chaudhary U and Bala K:
Detection of extended-spectrum beta lactamase in Pseudomonas
aeruginosa. Indian J Pathol Microbiol. 51:222–224. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jayakumar S and Appalaraju B: Prevalence
of multi and pan drug resistant Pseudomonas aeruginosa with
respect to ESBL and MBL in a tertiary care hospital. Indian J
Pathol Microbiol. 50:922–925. 2007.PubMed/NCBI
|
|
40
|
Sader HS, Reis AO, Silbert S and Gales AC:
IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced
by carbapenem-resistant Pseudomonas aeruginosa in a
Brazilian hospital. Clin Microbiol Infect. 11:73–76.
2005.PubMed/NCBI
|
